Hoth Therapeutics, Inc.
HOTH
$1.23
-$0.0198-1.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.98M | 4.90M | 4.97M | 4.69M | 4.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.19M | 9.72M | 8.40M | 7.97M | 7.93M |
| Operating Income | -10.19M | -9.72M | -8.40M | -7.97M | -7.93M |
| Income Before Tax | -10.19M | -9.70M | -8.37M | -7.95M | -7.91M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.19 | -9.70 | -8.37 | -7.95 | -7.91 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.19M | -9.70M | -8.37M | -7.95M | -7.91M |
| EBIT | -10.19M | -9.72M | -8.40M | -7.97M | -7.93M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.07 | -1.16 | -1.37 | -1.50 | -1.79 |
| Normalized Basic EPS | -0.67 | -0.72 | -0.86 | -0.93 | -1.11 |
| EPS Diluted | -1.07 | -1.16 | -1.37 | -1.50 | -1.79 |
| Normalized Diluted EPS | -0.67 | -0.72 | -0.86 | -0.93 | -1.11 |
| Average Basic Shares Outstanding | 40.12M | 33.82M | 25.49M | 22.54M | 19.12M |
| Average Diluted Shares Outstanding | 40.12M | 33.82M | 25.49M | 22.54M | 19.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |